Zdrowie i gospodarka · 27/10/2015

FDA Classifies Autosomal Recessive Carrier Screening Gene Mutation Detection System as Class II Device

The FDA has classified an autosomal recessive carrier screening gene mutation detection system into Class II, requiring special controls to ensure the device's safety and effectiveness, following a classification order that will be part of the codified language for this device classification.